Schonfeld Strategic Advisors LLC Werewolf Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$2.0 - $3.82 $303,956 - $580,555
-151,978 Reduced 46.52%
174,724 $373,000
Q2 2023

Aug 14, 2023
BUY
$2.31 - $3.65 $585,086 - $924,486
253,284 Added 344.99%
326,702 $996,000
Q1 2023

May 15, 2023
BUY
$1.98 - $4.3 $145,367 - $315,697
73,418 New
73,418 $190,000
Q3 2021

Nov 16, 2021
SELL
$13.89 - $20.31 $156,957 - $229,503
-11,300 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$11.6 - $17.44 $131,080 - $197,072
11,300 New
11,300 $197,000

Others Institutions Holding HOWL

# of Institutions
69
Shares Held
31.8M
Call Options Held
700
Put Options Held
500
View Full List

About Werewolf Therapeutics, Inc.

HOWL Quotes by TradingView
  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $47M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email